Bioactive Materials, Год журнала: 2025, Номер 51, С. 613 - 633
Опубликована: Май 28, 2025
Язык: Английский
Bioactive Materials, Год журнала: 2025, Номер 51, С. 613 - 633
Опубликована: Май 28, 2025
Язык: Английский
Materials Today Bio, Год журнала: 2025, Номер 32, С. 101778 - 101778
Опубликована: Апрель 17, 2025
Osteoarthritis (OA) is a progressive degenerative disorder which severely threatens the quality of life older individuals. OA progression closely related to heightened levels mitochondrial reactive oxygen species (mtROS). Although nanozymes have good ROS-scavenging effect, they cannot precisely scavenge mtROS because immune rejection cell membranes, lysosomal escape, and inability conventional directly target mitochondria. Dual-target were engineered in chondrocytes. We used chondrocyte membrane-camouflaged TPP-modified hollow Prussian blue subsequently encapsulated these hybrid glycyrrhizic acid hydrogel. The therapeutic efficacy underlying mechanisms assessed vitro vivo. novel enhanced selectivity, evasion capabilities, targeting. dual-targeted exerted pronounced impact on inflammatory chondrocytes, mitigated mtDNA leakage by scavenging mtROS, dampened cGAS-STING-NF-κB signaling, function. hydrogels also exhibited improved outcomes. confirmed beneficial effects nanozyme-hydrogel combination mice. can reduce avoiding suppressing signaling pathway, thereby decreasing responses alleviate progression.
Язык: Английский
Процитировано
0Bioactive Materials, Год журнала: 2025, Номер 51, С. 613 - 633
Опубликована: Май 28, 2025
Язык: Английский
Процитировано
0